Literature DB >> 9052920

Cord blood stem cell transplantation for Diamond-Blackfan anemia.

K Vettenranta1, U M Saarinen.   

Abstract

Bone marrow transplantation has been successfully employed in the treatment of Diamond-Blackfan anemia (DBA). Transplantation with bone marrow stem cells involves, however, considerable treatment-related toxicity, partially in the form of GVHD. Through the use of cord blood stem cells it may be possible to reduce the risk for both acute and chronic GVHD, although possibly in the face of an increased risk for non-engraftment. We report the successful treatment of a boy with DBA by cord blood stem transplantation from an HLA-identical sibling.

Entities:  

Mesh:

Year:  1997        PMID: 9052920     DOI: 10.1038/sj.bmt.1700675

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

Review 1.  Diamond-Blackfan Anaemia: an overview.

Authors:  I Dianzani; E Garelli; U Ramenghi
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 2.  Umbilical cord blood research: current and future perspectives.

Authors:  Jennifer D Newcomb; Paul R Sanberg; Stephen K Klasko; Alison E Willing
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

3.  Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.

Authors:  Shouichi Ohga; Hideo Mugishima; Akira Ohara; Seiji Kojima; Kohji Fujisawa; Keiko Yagi; Masamune Higashigawa; Ichiro Tsukimoto
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.